| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |